1AMINO

1AMINO is a synthetic biology company focused on expanding the genetic code to enable the production of proteins with non-canonical amino acids (ncAAs). Founded by researchers from Rice University, the company leverages orthogonal translation systems to incorporate novel chemical functionalities into proteins at specific sites. This platform technology aims to create a new generation of protein-based therapeutics and materials with enhanced stability, activity, and specificity. 1AMINO's approach allows for the precise engineering of proteins beyond the 20 standard amino acids, opening new possibilities for drug discovery and development.